251 related articles for article (PubMed ID: 16008514)
1. Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice.
Deng W; Han Q; Liao L; You S; Deng H; Zhao RC
DNA Cell Biol; 2005 Jul; 24(7):458-63. PubMed ID: 16008514
[TBL] [Abstract][Full Text] [Related]
2. Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.
Funakoshi S; Taub DD; Anver MR; Raziuddin A; Asai O; Reddy V; Rager H; Fanslow WC; Longo DL; Murphy WJ
J Clin Invest; 1997 Feb; 99(3):484-91. PubMed ID: 9022082
[TBL] [Abstract][Full Text] [Related]
3. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus.
Blossom S; Chu EB; Weigle WO; Gilbert KM
J Immunol; 1997 Nov; 159(9):4580-6. PubMed ID: 9379059
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
5. Effect of anti-CD134L mAb and CTLA4Ig on ConA-induced proliferation, Th cytokine secretion, and anti-dsDNA antibody production in spleen cells from lupus-prone BXSB mice.
Zhou YB; Ye RG; Li YJ; Xie CM; Wu YH
Autoimmunity; 2008 Aug; 41(5):395-404. PubMed ID: 18568645
[TBL] [Abstract][Full Text] [Related]
6. [Study of immuno-tolerance mechanism of the third-party bone marrow-derived mesenchymal stem cells in allogenic transplantation].
Qi BD; Meng BX; Yang Y; Liu B; Li CC; Xia W; Guo SZ; Zhang C
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):207-12. PubMed ID: 21838003
[TBL] [Abstract][Full Text] [Related]
7. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
[TBL] [Abstract][Full Text] [Related]
8. Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.
Hermankova B; Zajicova A; Javorkova E; Chudickova M; Trosan P; Hajkova M; Krulova M; Holan V
Immunobiology; 2016 Feb; 221(2):129-36. PubMed ID: 26416211
[TBL] [Abstract][Full Text] [Related]
9. Effect of mesenchymal stem cells on inhibiting airway remodeling and airway inflammation in chronic asthma.
Ge X; Bai C; Yang J; Lou G; Li Q; Chen R
J Cell Biochem; 2013 Jul; 114(7):1595-605. PubMed ID: 23334934
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice.
Chae BS; Shin TY
Arch Pharm Res; 2007 Feb; 30(2):191-8. PubMed ID: 17366741
[TBL] [Abstract][Full Text] [Related]
11. Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells.
Wada N; Bartold PM; Gronthos S
Stem Cells Dev; 2011 Apr; 20(4):647-59. PubMed ID: 20712449
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
Gu F; Molano I; Ruiz P; Sun L; Gilkeson GS
Clin Immunol; 2012 Nov; 145(2):142-52. PubMed ID: 23041504
[TBL] [Abstract][Full Text] [Related]
13. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system.
Zhang L; Su XS; Ye JS; Wang YY; Guan Z; Yin YF
Stem Cell Res Ther; 2015 Mar; 6(1):45. PubMed ID: 25889932
[TBL] [Abstract][Full Text] [Related]
15. Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCL2 expression.
Che N; Li X; Zhang L; Liu R; Chen H; Gao X; Shi S; Chen W; Sun L
J Immunol; 2014 Nov; 193(10):5306-14. PubMed ID: 25339674
[TBL] [Abstract][Full Text] [Related]
16. IL-10 inhibits lipopolysaccharide-induced murine B cell proliferation and cross-linking of surface antigen receptors or ligation of CD40 restores the response.
Marcelletti JF
J Immunol; 1996 Oct; 157(8):3323-33. PubMed ID: 8871628
[TBL] [Abstract][Full Text] [Related]
17. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
Tada Y; O-Wang J; Yu L; Shimozato O; Wang YQ; Takiguchi Y; Tatsumi K; Kuriyama T; Takenaga K; Sakiyama S; Tagawa M
Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
19. Macrophages enhance tumor-derived autophagosomes (DRibbles)-induced B cells activation by TLR4/MyD88 and CD40/CD40L.
Zhou M; Li W; Wen Z; Sheng Y; Ren H; Dong H; Cao M; Hu HM; Wang LX
Exp Cell Res; 2015 Feb; 331(2):320-30. PubMed ID: 25447440
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1 Transduced Mesenchymal Stem Cells Have Profound Modulatory Effects on DCs and T Cells.
Daneshmandi S; Karimi MH; Pourfathollah AA
Iran J Immunol; 2017 Mar; 14(1):13-23. PubMed ID: 28341815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
